Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Nov 29;12(12):2461.
doi: 10.3390/microorganisms12122461.

The First Report of mcr-1-Carrying Escherichia coli, Isolated from a Clinical Sample in the North-East of Romania

Affiliations

The First Report of mcr-1-Carrying Escherichia coli, Isolated from a Clinical Sample in the North-East of Romania

Mădălina-Alexandra Vlad et al. Microorganisms. .

Abstract

Colistin resistance poses a significant clinical challenge, particularly in Gram-negative bacteria. This study investigates the occurrence of plasmid-mediated colistin resistance among Enterobacterales isolates (Escherichia coli, Klebsiella pneumoniae, and Enterobacter spp.) and non-fermentative rods (Acinetobacter baumannii and Pseudomonas aeruginosa). We analyzed 114 colistin-resistant isolates that were selected, based on resistance phenotypes, and isolated between 2019 and 2023. To achieve this, we used the rapid immunochromatographic test, NG-Test® MCR-1; multiplex PCR for mcr-1 to mcr-8, and real-time PCR for mcr-1 and mcr-2. One E. coli isolate was identified as carrying the mcr-1 gene, confirmed by NG-Test® MCR-1, multiplex PCR and whole-genome sequencing. This strain, belonging to ST69, harbored four plasmids, harboring different antimicrobial resistance genes, with mcr-1 being located on a 33,304 bp circular IncX4 plasmid. No mcr-2 to mcr-8-positive isolates were detected, prompting further investigation into alternative colistin resistance mechanisms. This is the first report of a mcr-1-positive, colistin-resistant E. coli isolated from a human clinical sample in the North-East of Romania.

Keywords: E. coli; Enterobacterales; antimicrobial resistance; colistin resistance; mcr-1-mcr-8; whole-genome sequencing.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
A schematic circular representation of the E. coli IncX4 plasmid.

Similar articles

Cited by

References

    1. Terreni M., Taccani M., Pregnolato M. New antibiotics for multidrug-resistant bacterial strains: Latest research developments and future perspectives. Molecules. 2021;26:2671. doi: 10.3390/molecules26092671. - DOI - PMC - PubMed
    1. Laxminarayan R., Duse A., Wattal C., Zaidi A.K.M., Wertheim H.F.L., Sumpradit N., Vlieghe E., Hara G.L., Gould I.M., Goossens H., et al. Antibiotic resistance: The need for global solutions. Lancet Infect. Dis. 2013;13:1057–1098. doi: 10.1016/S1473-3099(13)70318-9. - DOI - PubMed
    1. Grégoire N., Aranzana-Climent V., Magréault S., Marchand S., Couet W. Clinical pharmacokinetics and pharmacodynamics of colistin. Clin. Pharmacokinet. 2017;56:1441–1460. doi: 10.1007/s40262-017-0561-1. - DOI - PubMed
    1. Paterson D.L., Harris P.N.A. Colistin resistance: A major breach in our last line of defence. Lancet Infect. Dis. 2016;16:132–133. doi: 10.1016/S1473-3099(15)00463-6. - DOI - PubMed
    1. Cheah S.E., Li J., Tsuji B.T., Forrest A., Bulitta J.B., Nation R.L. Colistin and Polymyxin B dosage regimens against Acinetobacter baumannii: Differences in activity and the emergence of resistance. Antimicrob. Agents Chemother. 2016;60:3921–3933. doi: 10.1128/AAC.02927-15. - DOI - PMC - PubMed

LinkOut - more resources